Download presentation
Presentation is loading. Please wait.
Published byArchibald Chambers Modified over 9 years ago
1
GENE-ENVIRONMENT INTERACTION Herman Autrup Dept Environmental Medicine Institute of Public Health University of Aarhus
2
Influence gene expression Interacts with gene – adducts coding sites – mutation transcription site – expression Gene product modifies effect of environmental risk factor GENE –ENVIRONMENT INTERACTIONS MECHANISM
3
Several Mechanistic Possibilities GENE-ENVIRONMENT- INTERACTION Risk Factor Genotype Disease Genotype enhances risk factor expression
4
Several Mechanistic Possibilities GENE-ENVIRONMENT- INTERACTION Risk Factor Genotype Disease Both genotype and risk factor affect disease
5
Several Mechanistic Possibilities GENE-ENVIRONMENT- INTERACTION Risk Factor Genotype Disease Risk factor alters gene/disease association
6
Several Mechanistic Possibilities GENE-ENVIRONMENT- INTERACTION Risk Factor Genotype Disease Genotype alters risk factor/disease association
7
Influence gene expression
8
Ah Arnt Cell membrane Cytoplasm ATP ADP + Pi Nuclear membrane XRE CYP1A1 Arnt Ah Nuclei Steroid Hormones vævsspecifikke transcription faktorer Negative regulatoriske elementer Phosphorylation
10
METAL TOXICITY - TRANSCRIPTOMES Andrew, Env Health Persp 111: 825-838, 2003
11
Interacts with genes - adducts
12
BULKY CARCINOGEN - DNA ADDUCT DNA: Lymphocytes Procedure: P32 postlabelling Enrichment:P1 nuclease Quantification: phosphor image DNA component 32 P-label resolve nucleotides
13
CARCINOGEN-DNA ADDUCTS AND EXPOSURE carc. PAH (ng/m 3 ) 0 20 40 60 80 14 12 10 8 6 4 2 0 DNA adducts / 10 8 nucl.) 0.1 1 10 100 carc. PAH (ng/m 3 ) DNA adducts / 10 8 nucl. 10 1 0.1 No correlation with inhaled PAH or other ambient air pollution parameters Thailand police: No correlation between total PAH and bulky DNA adduct levels Medical students, DK: No correlation between PM2.5 and bulky-carcinogen adduct levels Meta-analysis (Peluso et al, 2001): Significant association between PAH (and BP) and bulky-adducts in industrial workers.
14
CARCINOGEN-DNA ADDUCTS AND CANCER RISK Study design:Type of cancerRiskReference Cohort (smokers only)Lung1.22H. Bak, poster Porvoo Cohort (current smokers)Lung2.98Perera et al, 2002 Case-controlBladder1.9Benhamou et al, 2003 Case-controlBreast (PAH)1.97Rundle et al, 2002 Case-controlBreast (PhIP)4.03Zhu et al, 2003 Conclusion: Carcinogen-DNA adducts appears to be a risk indicator for cancer, especially in smokers
15
Effect modification
16
CANDIDATE GENES Low Penetrance: Phase I CYP1A1 PAH’s cigarette smoke CYP1A2 HAA’s cooked meat CYP2E1Nitrosaminesprocessed meat NAT1HAA’scooked meat NAT2HAA’scooked meat
17
CANDIDATE GENES Low Penetrance: Phase II NAT1, NAT2Arylaminescigarette smoke GSTPAH’s cigarette smoke HAA’s cooked meat
18
CANDIDATE GENES Some Problems Expressed in target tissue? Inducible? Polymorphisms functional? Dual role (NAT)
19
GST and GASTRIC CANCER – Meta analysis GSTM1 Deletion 1.24 + ever smoking 2.39 GSTT1 Deletion 1.08 + ever smoking 2.37 GSTM1 and T1 deletions 2.08 Boccia et al, Cancer Letter, 2005
20
GSTM1 and NEVER SMOKERS Passive smokers Total group Plus 1.00 Null 1.03 Null + null passive 0.52 + 1-19 h-years 0.77 + 20+ 2.32 Wenzloft et al, Carcinogenesis 2005
21
GSTM1 and ALCOHOL INTERACTION Esophegeal Gastric Alcohol 1.52 1.73 GSTM1 Del 2.17 1.02 GSTM1 + and low alcohol = 1 GSTM1 Del 3.76 1.34 high and GSTM1+ 4.00 3.48 high and Del 2.98 1.58
22
BIOTRANSFORMATION BENZENE NQO
23
BENZENE TOXICITY Benzene Benzene oxide Phenol Hydroquinone 1,4-Benzoquinone Risk Lack of NQO1 (2.6) High CYP2E1(2.5) Combined(7.8)
24
BENZENE : S-PHENYLMERCAPTURIC ACID (PMA) AND MUCONIC ACID (TMA) Low activity genotype = 100 Sørensen et al., 2003 Sources of benzene. Ambient air, cigarette smoking, grilling (charcoal) Population: Non-smoking medical students, Copenhagen, DK (ambient air benzene 2.53 ug/m 3 ) Significant difference TMAPMA
25
BULKY-ADDUCTS – EFFECT OF GSTM1 GSTM1*1/*1 = 100 LymphocytesTissues * Statistically significant PlacentaBreastLung * * * * ** Occupational studies
26
GENE-GENE INTERACTION Study population:Greek technical school students, non-smokers DNA adducts 0,00 0,25 0,50 0,75 1,00 1,25 1,50 1,752,00 all subjects high ETS exposure GSTM1 null GSTP1 ile/val & val/val mEH exon 4 0.026 0.011 0.025 0.009 0.002 CYP1A1*2+/+ CYP1A1*2 +/- & -/- non-inducible individuals (76.3%) inducible individuals (23.7%)
27
INTERACTION OF GSTM1 AND GSTP1 PAH-adducts – WBC OR GSTM1*2/*21.25 GSTP*2/1.44 GSTM1*2/*2 & GSTP*22.20 GSTM1 no effect in current smokers Strongest effect in former smokers Perera et al., Carcinogenesis, 2002
28
GENOTYPES AFFECTING BULKY-DNA ADDUCT LEVEL Gene CYP1A1 GSTM1 GSTT1 GSTP1 MPO NQO1 EH NAT2 Genotype *2/*2 *1/*1 Tyr113Tyr Slow Effect No effect Combinations
29
COMBINED EFFECT OF BIOMARKERS ON LUNG CANCER RISK Adduct levelGSTM1OR Lowpresent1.0 Lownull2.3 Highpresent6.9 High null16.2 Tang et al., Carcinogenesis 1998
30
GEN-AIR - OBJECTIVES Risk factors in smoking-related cancers in non-smokers ambient air environmental tobacco smoke susceptibility genes Bulky carcinogen-DNA adducts as risk indicator Gene-environment interactions
31
MOLECULAR EPIDEMIOLOGY Definition: Application of molecular markers of exposure and susceptibility in epidemiological studies
32
GEN-AIR - OBJECTIVES Risk factors in smoking-related cancers in non-smokers ambient air environmental tobacco smoke susceptibility genes Bulky carcinogen-DNA adducts as risk indicator Gene-environment interactions
33
GEN-AIR STUDY 271 lung cancer cases Risk factors: Passive smoking Ambient air pollution-residence Genetic polymorphism: 26 genes, 39 polymorphisms Bulky carcinogen-DNA adduct: risk indicator
34
STATISTICAL ANALYSIS Cox´s proportional hazard models Adjusted: Gender, age, smoking habits, time of recruitment, country, school year, energy intake, fruit & vegetable, physical activity, educational level
35
AMBIENT AIR POLLUTION Residence – road Estimated exposure – Residence and monitoring stations
36
LUNG CANCER RISK - RESIDENCE AOR No major road1.0 Moderately busy road1.52 Busy road1.22 Slightly higher risk for people living along roads with medium and high traffic
37
ETS EXPOSURE IN INFANCY Parental smoking HR Daily Ex-smokers1.65 Never smokers2.04 Daily – many hours Ex-smokers2.98 Never smokers3.63 Increased risk for lung cancer in people who has been exposed to ETS
38
SUSCEPTIBILITY GENES Xenobiotica metabolism: NAT1, NAT2, GSTM1, GSTM3, GSTT1, GSTP1, CYP1A1, CYP1B1, MPO, NQO1 DNA repair: ERCC1, ERCC3, ERCC5, OGT Others: MnSOD, BBRC1, RAD51, TP53 Total: 29 genes, 36 polymorphisms
39
SUSCEPTIBILITY GENES Metabolism genesOR CYP1A1*2/*23.0 (0.5 - 18.1) CYP1B1*2/*21.2 (0.5 - 2.6) GSTM1*2/*21.1 (0.7 - 1.9) GSTP1*2/*21.8 (1.8 - 3.9) NQO1*8.0 (1.7 - 37.2) No major role of these genes on lung cancer risk in low exposure situations
40
RISK GENOTYPES RISK ALLELE : The genotypes associated with an increased risk of cancer in previous studies
41
GENE-ENVIRONMENT INTERACTION Ambient air Less than 3 polymorphism 3+ polymorphic alleles No major road 1.0 Type A/B 1.40 2.19 AOR
42
GENE-ENVIRONMENT INTERACTION Environmental tobacco smoke 3+ polymorphic alleles Less than 3 polymorphism NO 2.97 1 YES 3.96 1.43 In case of ETS exposure increased risk with increasing number of at risk genotypes (trend P < 0.01) AOR
43
CARCINOGEN DNA ADDUCTS Involved in initiation of cancer – mutation Related to exposure Indicator of cancer risk – integrating exposure and genetic susceptibility
44
BULKY ADDUCT AS RISK INDICATOR Detectable vs non-detectable AOR All subjects1.82 Never smokers2.26 Ex-smokers2.24 Persons with detectable adduct level have an increased risk of developing cancer
45
ADDUCTS AND LUNG CANCER Only people with detectable adducts All subjectbelow1.93 above1.51 Never smokersbelow1.78 above4.04 Ex-smokersbelow3.91 above1.20 Never-smokers with an above median adduct level have an increased risk of lung cancer
46
N= 0 1 2 3 4 5 DNA ADDUCTS AND SUSCEPTIBILITY Adduct level increases with number of risk alleles
47
GENETIC POLYMORPHISM IN XENOBIOTICA METABOLIZING ENZYMES Cytochrome P450:CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2E1, CYP3A4, Glutathione S-Transferase:GSTM1, GSTT1, GSTP1, GSTA1 Others:NQO1, MPO, mEH
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.